Host gene expression profiling of cervical smear is eligible for cancer risk evaluation

Journal of Clinical Pathology

Volumn 66, Issue 4, 2013, Pages 282-285

  Bourmenskaya, Olga ^a   Shubina, Ekaterina ^a,b   Trofimov, Dmitry ^a,b   Rebrikov, Denis ^a,b   Sabdulaeva, Elina ^c   Nepsha, Oksana ^a   Bozhenko, Vladimir ^d   Rogovskaya, Svetlana ^e   Sukhikh, Gennady ^a  

^a RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

^b MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d Ministry of Health of the Russian Federation   (Russian Federation)

^e Russian Medical Academy of Postgraduate Education   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MKI67 PROTEIN; PEPTIDOGLYCAN RECOGNITION PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN BAX; PTGS2 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CARCINOGENESIS; FEMALE; GENE EXPRESSION PROFILING; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CELL PROLIFERATION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHI-SQUARE DISTRIBUTION; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; RNA, VIRAL; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 84875228813     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2012-201313     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Wentzensen N, Klug SJ. Early detection of cervical carcinomas: Finding an overall approach. Dtsch Arztebl Int 2008;105:617-22.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24(Suppl 3):1-10.
5. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368-83.
6. Zur Hausen H. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
7. Cattani P, Siddu A, D'Onghia S, et al. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 2009;47:2136-41.
8. Yugawa T, Kiyono T. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: Novel functions of E6 and E7 oncoproteins. Rev Med Virol 2009;19:97-113.
9. Solomon D, Davey D, Kurman R, et al., Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-19.
10. Clifford GM, Rana RK, Franceschi S, et al. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1157-64.
11. Clifford GM, Smith JS, Aguado T, et al. Comparison of HPV type distribution in highgrade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 2003;89:101-5.
12. Board P, Coggan M, Johnston P, et al. Genetic heterogeneity of the human glutathione transferases: A complex of gene families. Pharm Ther 1990;48:357-69.
13. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic classification of human papillomaviruses: Correlation with clinical manifestations. J Gen Virol 1992;73:2653-60.
14. Narechania A, Chen Z, DeSalle R, et al. Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol 2005;79:15503-10.
15. Gravitt PE, Kovacic MB, Herrero R, et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 2007;121:2787-93.
16. Bruno S, Darzynkiewicz Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40.
17. OMIM. http://omim.org/entry/600160 (accessed Oct 2012)
18. Moriishi T, Maruyama Z, Fukuyama R, et al. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis. PLoS One 2011;6:e27487.
19. van Slooten HJ, van de Vijver MJ, van de Velde CJ, et al. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer 1998;77:789-96.
20. OMIM. http://omim.org/entry/600262 (accessed Oct 2012)
21. Greenhough A, Wallam CA, Hicks DJ, et al. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene 2010;29:3398-410.
22. Williams CS, Tsujii M, Reese J, et al. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105:1589-94.
23. Mutter GL. Pten, a protean tumor suppressor. Am J Pathol 2001;158:1895-8.
24. Baak JP, Van Diermen B, Steinbakk A, et al. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Hum Pathol 2005;36:555-61.